Changes in bone mineral density in patients with Paget's disease treated with risedronate - Wikidata - wikimedia - TriplyDB

Changes in bone mineral density in patients with Paget's disease treated with risedronate

Changes in bone mineral density in patients with Paget's disease treated with risedronate

http://www.wikidata.org/entity/Q32107190

about

Factors associated with self-rated health in patients with Paget's disease of bone.

P2860

Q40794980-80DA4476-66B6-4C0F-AC63-AAF0EE903BC1

P2860

Changes in bone mineral density in patients with Paget's disease treated with risedronate

http://www.wikidata.org/entity/Q32107190

description

1997 nî lūn-bûn

@nan

1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Changes in bone mineral density in patients with Paget's disease treated with risedronate

@ast

Changes in bone mineral density in patients with Paget's disease treated with risedronate

@en

type

label

Changes in bone mineral density in patients with Paget's disease treated with risedronate

@ast

Changes in bone mineral density in patients with Paget's disease treated with risedronate

@en

prefLabel

Changes in bone mineral density in patients with Paget's disease treated with risedronate

@ast

Changes in bone mineral density in patients with Paget's disease treated with risedronate

@en

P1433

Q32107190-2EFE12CB-E3E1-4086-BFA0-59F69CF65578

P1476

Q32107190-886BD35E-8D35-4BD0-AEAF-A1517CF307FE

P2093

Q32107190-181966FF-4313-4BF5-A393-981BD995C600

Q32107190-4BA715A1-E442-42F4-AEE7-CE3BF963972A

Q32107190-666C95BF-D997-4F80-BE46-99B499512BD8

Q32107190-C6B8E619-F294-4D36-AF64-6F76429CC1DD

Q32107190-E6D75369-4D25-4CB0-9B06-082A3D50AA7F

Q32107190-EC195066-EF98-43F1-90DB-7EA19CD6129D

P2860

Q32107190-13E82FB0-3568-4110-9E65-876E4A55C9F1

Q32107190-4DAF07BA-7A69-48F2-8A1A-3E3CD6A756C0

Q32107190-646EA342-8A52-424A-A85E-C743E89B2E29

Q32107190-684A9AD3-8F12-46FE-B568-E5E4464B2430

Q32107190-6F0AFEAC-393F-4118-A2F2-FB37BC26808F

Q32107190-861CE5ED-1C57-4E28-B146-3CB1BABB3348

Q32107190-A50A94A7-A326-40A3-AF20-BED53C71E803

Q32107190-CEB73986-F5C5-4BDA-B202-F3B3F78DE5A7

Q32107190-F756FA7A-7A21-4FB3-B0C3-82DC9CA9C08C

Q32107190-FC848988-5EDF-460A-906D-F8982B46523D

P304

Q32107190-8CFDAF40-7F63-4085-BD42-E28B27862BD0

P31

Q32107190-3A0DF2AE-70B5-4E18-A940-C9C2C43350E8

P356

Q32107190-B1B69CBF-7359-41E3-8ED3-AD61A7710266

P407

Q32107190-ADFA8D0A-BBE9-4E65-A42B-652FF6A76D01

P433

Q32107190-7A9936D2-4666-4C75-9482-C3279468D75E

P478

Q32107190-28B3D66B-005C-4441-A306-C645BDF8DE11

P577

Q32107190-6198E582-17AB-43B1-9E09-8AD9BA5EF2F1

P5875

Q32107190-8232B33F-E729-4323-A85F-FEA099AA21E5

P698

Q32107190-37574B1C-C72F-4F81-A5B5-7083DB554DAD

P932

Q32107190-6B1244EA-21E2-472E-A56E-9E9811FBFCB3

P356

P1433

Annals of the Rheumatic Diseases

P1476

Changes in bone mineral density in patients with Paget's disease treated with risedronate

@en

P2093

Bhallah A

http://www.w3.org/2001/XMLSchema#string

Hosking DJ

http://www.w3.org/2001/XMLSchema#string

Maslanka W

http://www.w3.org/2001/XMLSchema#string

Patel S

http://www.w3.org/2001/XMLSchema#string

Pearson D

http://www.w3.org/2001/XMLSchema#string

White DA

http://www.w3.org/2001/XMLSchema#string

P2860

Precision of total-body and regional bone mineral measurement by dual-energy X-ray absorptiometry.

Current and potential future drug treatments for osteoporosis.

Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.

Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.

Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Current methods and recent advances in the diagnosis of osteoporosis.

Paget's disease and osteoclast biology.

Diphosphonates inhibit human osteoblast secretion and proliferation.

Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone.

Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium.

P304

405-409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.56.7.405

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

1997-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13745669

http://www.w3.org/2001/XMLSchema#string

P698

9486001

http://www.w3.org/2001/XMLSchema#string

P932

1752415

http://www.w3.org/2001/XMLSchema#string